Literature DB >> 19823873

Transposable elements in disease-associated cryptic exons.

Igor Vorechovsky1.   

Abstract

Transposable elements (TEs) make up a half of the human genome, but the extent of their contribution to cryptic exon activation that results in genetic disease is unknown. Here, a comprehensive survey of 78 mutation-induced cryptic exons previously identified in 51 disease genes revealed the presence of TEs in 40 cases (51%). Most TE-containing exons were derived from short interspersed nuclear elements (SINEs), with Alus and mammalian interspersed repeats (MIRs) covering >18 and >16% of the exonized sequences, respectively. The majority of SINE-derived cryptic exons had splice sites at the same positions of the Alu/MIR consensus as existing SINE exons and their inclusion in the mRNA was facilitated by phylogenetically conserved changes that improved both traditional and auxiliary splicing signals, thus marking intronic TEs amenable for pathogenic exonization. The overrepresentation of MIRs among TE exons is likely to result from their high average exon inclusion levels, which reflect their strong splice sites, a lack of splicing silencers and a high density of enhancers, particularly (G)AA(G) motifs. These elements were markedly depleted in antisense Alu exons, had the most prominent position on the exon-intron gradient scale and are proposed to promote exon definition through enhanced tertiary RNA interactions involving unpaired (di)adenosines. The identification of common mechanisms by which the most dynamic parts of the genome contribute both to new exon creation and genetic disease will facilitate detection of intronic mutations and the development of computational tools that predict TE hot-spots of cryptic exon activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823873     DOI: 10.1007/s00439-009-0752-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  156 in total

1.  Alu-containing exons are alternatively spliced.

Authors:  Rotem Sorek; Gil Ast; Dan Graur
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

2.  The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.

Authors:  Delphine Galiana-Arnoux; Fabrice Lejeune; Marie-Claude Gesnel; James Stevenin; Richard Breathnach; Fabienne Del Gatto-Konczak
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

Review 3.  The ribozyme core of group II introns: a structure in want of partners.

Authors:  François Michel; Maria Costa; Eric Westhof
Journal:  Trends Biochem Sci       Date:  2009-03-18       Impact factor: 13.807

4.  Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNA.

Authors:  M Selvakumar; D M Helfman
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

5.  Alu sequences in the coding regions of mRNA: a source of protein variability.

Authors:  W Makałowski; G A Mitchell; D Labuda
Journal:  Trends Genet       Date:  1994-06       Impact factor: 11.639

6.  Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.

Authors:  Isabel Aznarez; Elayne M Chan; Julian Zielenski; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

7.  DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.

Authors:  Olga L Gurvich; Therese M Tuohy; Michael T Howard; Richard S Finkel; Livija Medne; Christine B Anderson; Robert B Weiss; Steve D Wilton; Kevin M Flanigan
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

8.  Exon creation and establishment in human genes.

Authors:  André Corvelo; Eduardo Eyras
Journal:  Genome Biol       Date:  2008       Impact factor: 13.583

9.  Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.

Authors:  Massimo Buvoli; Ada Buvoli; Leslie A Leinwand
Journal:  PLoS One       Date:  2007-05-09       Impact factor: 3.240

10.  The RNAz web server: prediction of thermodynamically stable and evolutionarily conserved RNA structures.

Authors:  Andreas R Gruber; Richard Neuböck; Ivo L Hofacker; Stefan Washietl
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

View more
  53 in total

Review 1.  The role of Alu elements in the cis-regulation of RNA processing.

Authors:  Chammiran Daniel; Mikaela Behm; Marie Öhman
Journal:  Cell Mol Life Sci       Date:  2015-07-30       Impact factor: 9.261

2.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

Review 3.  Pre-mRNA splicing in disease and therapeutics.

Authors:  Ravi K Singh; Thomas A Cooper
Journal:  Trends Mol Med       Date:  2012-07-18       Impact factor: 11.951

Review 4.  Antisense mediated splicing modulation for inherited metabolic diseases: challenges for delivery.

Authors:  Belen Pérez; Lluisa Vilageliu; Daniel Grinberg; Lourdes R Desviat
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

Review 5.  Nuclear function of Alus.

Authors:  Chen Wang; Sui Huang
Journal:  Nucleus       Date:  2014-02-04       Impact factor: 4.197

Review 6.  Alu elements: know the SINEs.

Authors:  Prescott Deininger
Journal:  Genome Biol       Date:  2011-12-28       Impact factor: 13.583

Review 7.  Living Organisms Author Their Read-Write Genomes in Evolution.

Authors:  James A Shapiro
Journal:  Biology (Basel)       Date:  2017-12-06

Review 8.  Deep intronic mutations and human disease.

Authors:  Rita Vaz-Drago; Noélia Custódio; Maria Carmo-Fonseca
Journal:  Hum Genet       Date:  2017-05-12       Impact factor: 4.132

Review 9.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

10.  The intronic splicing code: multiple factors involved in ATM pseudoexon definition.

Authors:  Ashish Dhir; Emanuele Buratti; Maria A van Santen; Reinhard Lührmann; Francisco E Baralle
Journal:  EMBO J       Date:  2010-01-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.